UTSW Blackstone Launchpad Speaker Series: Biotech Moonshots and Startup Liftoff from Lab to Launch
Join us for a seminar, featuring Karl Handelsman. He will walk you through the journey of becoming a founder and entrepreneur through his talk titled Biotech Moonshots and Startup Liftoff from Lab to Launch.
Karl Handelsman is the Founder and General Partner of Codon Capital, established in 2013 to invest in early-stage biotech teams uniquely qualified to build breakthrough technical solutions in therapeutics and synthetic biology. Karl has been working with extraordinary teams that have a track record of success for over 20 years. Codon supports teams in advance of the Series A to discover the highest value product for their technology. Codon also helps teams establish a capital efficient development plan with the goal of demonstrating value within 18 months of the Series A financing.Karl gained unique experience to his approach while also serving as Senior Advisor, Roche Venture Fund from 2016 – Jan 2021. Previously a Managing Director at CMEA Ventures, a major venture fund, Karl led biotech investments (managing four funds in size from $40M to $400M) over 14 years. In previous business development roles, Karl worked at Tularik and Millennium. He is Chairman of the Board of Good Therapeutics, a company building a new class of protein drugs that are only active when bound to a target molecule. Karl received an MBA, Sloan School of Business, MIT; an MS in Genetics, Harvard Medical School; and a BA, Boston University.